The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Mar 2017, Volume 24, Issue 2
March’s edition of the EJHP includes an editorial on “Value or cost”, and original articles on: evaluation of a pharmaceutical assessment screening tool; biosimilar infliximab for the management of rheumatoid arthritis; the cost and efficiency of incident reporting in a specialist paediatric NHS hospital and impact on patient safety; ready-to-use parenteral amiodarone; and much more.
The edition also contains a case report on bradycardia associated with pegylated liposomal doxorubicin administration, as well as a postcript on deprescribing in India: will we ever get down to it?.